Peripheral Artery Disease (PAD)

This channel includes news, interventions, and new technology innovations for peripheral artery diease, PAD and critical limb ischemia. 

News

May 4, 2012 - A new balloon catheter system could advance the endovascular approach to treating obstructed arteries in ...

Home May 04, 2012
Home
Feature

April 17, 2012 –– Expanding its commitment to developing innovative treatments for cardiovascular disease and the ...

Home April 17, 2012
Home
Technology

March 16, 2012 — The U.S. Food and Drug Administration (FDA) approved the premarket approval (PMA) application for the ...

Home March 16, 2012
Home
News

March 9, 2012 — Avinger Inc. announced the enrollment of the first U.S. patient in the CONNECT II global clinical trial ...

Home March 09, 2012
Home
News

March 6, 2012 — In a development that brings advanced combination therapy treatment of peripheral artery disease (PAD) t ...

Home March 06, 2012
Home
News

March 6, 2012 — Vascular Magnetics announced it has raised $7 million to advance development of a drug delivery system ...

Home March 06, 2012
Home
Technology

February 9, 2012 — Boston Scientific announced the United States launch of the TruePath CTO device, designed to ...

Home February 09, 2012
Home
News

January 18, 2012 — Boston Scientific reported nine-month clinical endpoint data from its ORION trial, demonstrating ...

Home January 18, 2012
Home
News

January 13, 2012 — Amorcyte Inc.,a NeoStem Inc. company, announced the expansion of intellectual property protection ...

Home January 13, 2012
Home
News

December 22, 2011 ­– Abbott today announced the initiation of ESPRIT I, a first-of-its-kind clinical trial in Europe ...

Home December 22, 2011
Home
Technology

December 13, 2011 – Boston Scientific announced the U.S. launch of its Charger PTA Balloon Catheter, a 0.035-inch ...

Home December 13, 2011
Home
News

November 23, 2011 – Vascular occlusions are blocked blood vessels caused by a blood clot in an artery. Blocks in the ...

Home November 23, 2011
Home
News

November 14, 2011 – Boston Scientific welcomed positive outcomes from the COBRA clinical trial, which evaluated post ...

Home November 14, 2011
Home
News

November 14, 2011 – Medrad Inc. announced that five-year data from the THUNDER trial [1] demonstrated a 59 percent ...

Home November 14, 2011
Home
Technology

November 4, 2011 — Medtronic Inc. announced approval by the U.S. Food and Drug Administration (FDA) of the Assurant ...

Home November 04, 2011
Home
Subscribe Now